Beställningsvara. Skickas inom 7-10 vardagar. Fri frakt över 249 kr.
Beskrivning
Leading researchers in health care write about Archie Cochrane and his work, examining the legacy he left in research methods that have begun to revolutionise policy making and the delivery of health care today. Includes chapters on epidemiology, effectiveness, efficiency, equity, and evolution
Alan Keith Maynard was a British health economist. Born in Bebington, Maynard studied at the Universities of Newcastle upon Tyne and York. After a stint at the University of Exeter, he was appointed to the University of York in 1971. Iain Chalmers is the editor of Non-Random Reflections: On Health Services Research: On the 25th Anniversary of Archie Cochrane's Effectiveness and Efficiency, published by Wiley.
Innehållsförteckning
Contributors vii Foreword xiiiAcknowledgements xvIntroductory reminiscences 1Archie Cochrane's legacy: an American perspective 3 Kerr L WhiteA reminiscence of Archie Cochrane 7Richard DollArchie Cochrane: an appreciation 11 Dick CohenArchie and the Nuffield Provincial Hospitals Trust 14 Gordon McLachlan``What have Communism and Catholicism against randomised controlled trials?'' 18 Andre Rougemont, Etienne Guberan Some reactions to Effectiveness and Efficiency 21 Hugh F ThomasPart 1: Epidemiology 29 Response rates in south Wales 1950--96: changing requirements for mass participation in human research 31Julian Tudor Hart, George Davey SmithCochrane and the benefits of wine 58 Richard DollThe epidemiology of asthma 75 Michael BurrPart 2: Effectiveness 91So what's so special about randomisation? 93 Jos Kleijnen, Peter Gøtzsche, Regina A Kunz, Andy D Oxman, Iain ChalmersCochrane and the benefits of aspirin 107 Peter ElwoodSocial work: beyond control? 122 Geraldine MacdonaldPart 3: Efficiency 147Health economics: has it fulfilled its potential? 149 Alan Maynard, Trevor A SheldonPart 4: Equity 167 Beyond effectiveness and efficiency...lies equality! 169 Alan WilliamsEquitable distribution of the risks and benefits associated with medical innovations 184 William SilvermanPart 5: Evolution 195Large-scale randomised evidence: trials and overviews 197Rory Collins, Richard Peto, Richard Gray, Sarah ParishThe Cochrane Collaboration 231 Iain Chalmers, David Sackett, Chris SilagyImproving the reporting of randomised controlled trials 250David Moher, Jesse Berlin Exploring lay perspectives on questions of effectiveness 272 Sandy OliverCochrane's obituary 292Index 295